Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002 (Q61657114)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

title

Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

Piergiorgio Duca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Schiavini M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

Angeli E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

Mainini A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

Gubertini G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

Vago L

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

Fociani P

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

Giorgi R

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

Cargnel A

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

331-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

Hepatitis C virus infection

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Care of patients with hepatitis C and HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Pathologic features of chronic hepatitis. A review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Natural history of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

The influence of host factors on the natural history of chronic hepatitis C viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Improved detection of hepatocyte proliferation using antibody to the pre-replication complex: an association with hepatic fibrosis and viral replication in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Cytokine production in saquinavir treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Regression of liver fibrosis in patients treated by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

Long-term administration of interferon-alpha in non-responder patients with chronic hepatitis C: follow-up of liver fibrosis over 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2006.00384.X

10.1111/J.1468-1293.2006.00384.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16945079 AND SRC:MED&resulttype=core&format=json

29 December 2019

1 reference